With the onset of the 21st century, there has been a veritable explosion of ophthalmic research. Eyesight, with its uncompromising care in the delivery of state-of-the-art eye care, is committed to enhancing the health of our population through excellence in research, by assisting in the research and delivery of new ocular therapies as well as to insure that these new ocular therapies become available to our patients as soon as possible.
With over 12 years’ experience and certified clinical research personnel, Eyesight has conducted over 90 clinical research studies and has demonstrated its ability to conduct clinical research studies of all phases in several sub-specialty areas of ophthalmology; from new antibiotics for conjunctivitis to novel treatments for dry eye syndrome and age-related macular degeneration, to the latest emerging computer assisted techniques for LASIK.
Eyesight currently has several clinical research studies enrolling patients and is continuously adding new clinical research studies for possible treatment options. If you are interested in learning more or participating in a clinical research study, please contact our clinical research department for further details at 603-501-7850, by email at SVasquez@eyesightnh.com.
Eyesight is currently enrolling patients for the following studies:
The OTX-16-002 study for patients with ocular hypertension or open angle glaucoma.